The NOS3 (27-bp repeat, intron 4) polymorphism is associated with susceptibility to osteomyelitis

Victor Asensi1, A Hugo Montes, Eulalia Valle

  • 1Infectious Diseases Unit, Hospital Central de Asturias, Oviedo University Medical School, Celestino Villamil s/n, 33006 Oviedo, Spain. vasensia@medynet.com <vasensia@medynet.com>

Insights

A specific NOS3 gene variation (27-bp repeat, intron 4 polymorphism, allele 4) is linked to increased nitric oxide (NO) and higher osteomyelitis risk. This finding offers new insights into bone infection pathogenesis.

Area of Science:

  • Genetics
  • Immunology
  • Bone Biology

Background:

  • Nitric oxide (NO) produced by nitric oxide synthase (NOS) isoforms, NOS3 and NOS2, in osteoblasts and neutrophils contributes to bone loss.
  • Osteomyelitis (OM) is a chronic bone infection where NO dysregulation may play a role.

Purpose of the Study:

  • To investigate the association between specific polymorphisms in NOS3 and NOS2 genes and the risk of developing osteomyelitis.
  • To examine the relationship between these polymorphisms, serum NO levels, and NO production in neutrophils and osteoblasts in OM patients.

Main Methods:

  • Genotyping of NOS3 (intron 4, 27-bp repeat; promoter -786T/C; exon 7 E298D) and NOS2 (exon 22 G/A; microsatellites; promoter -954G/C) polymorphisms in 80 OM patients and 300 controls.
  • Measurement of serum NO levels.
  • Assessment of NO production in neutrophils and immunolabelling for NOS3 in osteoblasts from biopsy tissues.

Main Results:

  • Homozygosity for the NOS3 (27-bp repeat, intron 4 polymorphism) 4 allele was significantly more frequent in OM patients (p=0.044).
  • Higher serum NO levels were observed in OM patients with this specific NOS3 polymorphism.
  • Neutrophils from these patients produced more NO in response to bacterial stimuli.
  • NOS3 expression in osteoblasts correlated with bone inflammation, not specific polymorphisms.

Conclusions:

  • This study identifies a significant association between a specific NOS3 polymorphism (27-bp repeat, intron 4, allele 4) and an increased risk of osteomyelitis.
  • This NOS3 variant may influence NO production, contributing to the pathogenesis of OM.
  • Further research is warranted to elucidate the precise mechanisms linking this NOS3 polymorphism to bone infection susceptibility.

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...